LEASE AGREEMENT BY AND BETWEEN HILLSIDE SQUARE LLC, LESSOR, -and- FLOUROPHARMA, INC., LESSEE LEASED PREMISES: HILLSIDE SQUARE SUITE 207 MONTCLAIR, NEW JERSEY 07042Lease Agreement • November 14th, 2011 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances
THIS LEASE AGREEMENT is made this 8th day of September, 2011 by and between HILLSIDE SQUARE LLC, a New Jersey limited liability company (“Lessor”) whose address is c/o The Bravitas Group, 105 Grove Street, Montclair, New Jersey 07042, and FLOUROPHARMA, INC., a corporation (“Lessee”), whose principal office is located at 500 Boylston Street, Suite 1600, Boston, Massachusetts 02116. .
FLUOROPHARMA, INC.Letter Agreement • November 14th, 2011 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances
Position and Duties. Upon your acceptance of this offer, you will serve as the President and Chief Executive Officer of FluoroPharma commencing on May 1, 2011, and continuing thereafter at the pleasure of the Board of Directors. As President and Chief Executive Officer, you will be responsible for overseeing the business and financial affairs of FluoroPharma under the direction of the Board of the Directors, and will report directly to the Board of Directors. You will be a part-time employee of FluoroPharma until such time as FluoroPharma shall have closed on its current round of funding. You will manage your time commitments consistent with your obligations to FluoroPharma. You join the Board of Directors of FluoroPharma.
OFFICE USE AGREEMENTOffice Use Agreement • November 14th, 2011 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
This Agreement is by and between PureTech Ventures, LLC ("PureTech") and FluoroPharma Medical, Inc. ("FluoroPharma") as of June 22, 2011 the ("Effective Date").
